SIRT1 and Burkitt lymphoma: In a study of Burkitt lymphoma, it was demonstrated that the use of LDH-specific inhibitors could result in a reduction in MYC protein levels through NAD/NADH-dependent inhibition of sirtuin-1, thereby depriving BL cells of the most important survival signal (Vettraino et al., 2013).